On behalf of the In Silico Pharmacology (Springer) editorial board, we would like to invite papers at the interface between computational neuroscience, artificial intelligence, machine learning and neuropharmacology.
In Silico Pharmacology provides a forum for peer-reviewed research articles at the cross-roads of computation, neuroscience, pharmacology and toxicology. It is anticipated that all computational and experimental approaches are represented within In Silico Pharmacology.
The journal primarily publishes interdisciplinary papers that address computational approaches in multi-scale analysis of bioactive substances from the cellular up to behavioral level as well as drug-design. The journal especially encourages deterministic and stochastic modeling of biological (e.g., biochemical, biophysical and immunological) processes leading to therapeutic advancements, as well as mathematical methods characterizing the pharmacology of substances within the living organism. Papers investigating substance- or material-induced morphological and genetic alterations are also welcome.